Acticor Biotech SA
PAR:ALACT
Acticor Biotech SA
Revenue
Acticor Biotech SA
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Acticor Biotech SA
PAR:ALACT
|
Revenue
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Valneva SE
PAR:VLA
|
Revenue
€224.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nanobiotix SA
PAR:NANO
|
Revenue
€30.1m
|
CAGR 3-Years
744%
|
CAGR 5-Years
204%
|
CAGR 10-Years
67%
|
|
Innate Pharma SA
PAR:IPH
|
Revenue
€51.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
15%
|
|
G
|
Genfit SA
PAR:GNFT
|
Revenue
€38.2m
|
CAGR 3-Years
70%
|
CAGR 5-Years
38%
|
CAGR 10-Years
20%
|
Abivax SA
PAR:ABVX
|
Revenue
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Acticor Biotech SA's Revenue?
Revenue
0
EUR
Based on the financial report for Jun 30, 2023, Acticor Biotech SA's Revenue amounts to 0 EUR.